[1] | Liakopoulos OJ, Teucher N, Muhlfeld C (2006) Prevention of TNFalpha-associated myocardial dysfunction resulting from cardiopulmonary bypass and cardioplegic arrest by glucocorticoid treatment. Eur J Cardiothorac Surg 30: 263–270.
|
[2] | Aikawa R, Nawano M, Gu Y (2000) Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt. Circulation 102: 2873–2879.
|
[3] | Mosnier LO, Zlokovic BV, Griffin JH (2007) The cytoprotective protein C pathway. Blood 109: 3161–3172.
|
[4] | Griffin JH, Fernandez JA, Liu D, Cheng T, Guo H, et al. (2004) Activated protein C and ischemic stroke. Crit Care Med 32: S247–253.
|
[5] | Mosnier LO, Griffin JH (2003) Inhibition of staurosporine-induced apoptosis of endothelial cells by activated protein C requires protease-activated receptor-1 and endothelial cell protein C receptor. Biochem J 373: 65–70.
|
[6] | Nick JA, Coldren CD, Geraci MW (2004) Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood 104: 3878–3885.
|
[7] | Abraham E (2005) Effects of recombinant human activated protein C in human models of endotoxin administration. Proc Am Thorac Soc 2: 243–247.
|
[8] | Feistritzer C, Riewald M (2005) Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. Blood 105: 3178–3184.
|
[9] | Yamauchi T, Sakurai M, Abe K, Takano H, Sawa Y (2006) Neuroprotective effects of activated protein C through induction of insulin-like growth factor-1 (IGF-1), IGF-1 receptor, and its downstream signal phosphorylated serine-threonine kinase after spinal cord ischemia in rabbits. Stroke 37: 1081–1086.
|
[10] | Guo H, Liu D, Gelbard H (2004) Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3. Neuron 41: 563–572.
|
[11] | Yamanel L, Mas MR, Comert B (2005) The effect of activated protein C on experimental acute necrotizing pancreatitis. Crit Care 9: R184–190.
|
[12] | Mizutani A, Okajima K, Uchiba M, Noguchi T (2000) Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood 95: 3781–3787.
|
[13] | Finigan JH, Dudek SM, Singleton PA (2005) Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation. J Biol Chem 280: 17286–17293.
|
[14] | Jakson CJ, Xue M, Thompson P (2005) Activated protein C prevents inflammation yet stimulates angiogenesis to promote cutaneous wound healing. Wound Repair Regen 13: 284–294.
|
[15] | Fernandez JA, Vento AE, Jormalainen M (2006) Activated protein C in the cardioplegic solution on a porcine model of coronary ischemia-reperfusion has deleterious hemodynamic effects. Cardiovasc Drugs Ther 20: 113–121.
|
[16] | Morissette MR, Rosenzweig A (2005) Targeting survival signaling in heart failure. Curr Opin Pharmacol 5: 165–170.
|
[17] | Fukui S, Kitagawa-Sakakida S, Sawa Y (2008) Therapeutic effect of midkine on cardiac remodeling in infarcted rat hearts. Ann Thirac Surg 85: 562–70.
|
[18] | Ono M, Sawa Y, Ryugo M (2005) BH4 peptide derivative from Bcl-xL attenuates ischemia/reperfusion injury thorough anti-apoptotic mechanism in rat hearts. Eur J Cardiothorac Surg 27: 117–121.
|
[19] | Chang WL, Chung CH, Wu YC, Su MJ (2004) The vascular and cardioprotective effects of liriodenine in ischemia-reperfusion injury via NO-dependent pathway. Nitric Oxide 11: 307–315.
|
[20] | Nagoshi T, Matsui T, Aoyama T (2005) PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J Clin Invest 115: 2128–2138.
|
[21] | Isobe H, Okajima K, Uchiba M (2001) Activated protein C prevents endotoxin-induced hypotension in rats by inhibiting excessive production of nitric oxide. Circulation 104: 1171–1175.
|
[22] | Favory R, Lancel S, Marechal X, Tissier S, Neviere R (2006) Cardiovascular protective role for activated protein C during endotoxemia in rats. Intensive Care Med 32: 899–905.
|
[23] | Pirat B, Muderrisoglu H, Unal MT (2007) Recombinant human-activated protein C inhibits cardiomyocyte apoptosis in a rat model of myocardial ischemia-reperfusion. Coron Artery Dis 18: 61–66.
|
[24] | Loubele ST, Spek A, Leenders P, van Oerle R, Aberson HL, et al. (2009) Activated Protein C Protects Against Myocardial Ischemia/Reperfusion Injury via Inhibition of Apoptosis and Inflammation. Arterioscler Tromb Vasc Biol 29: 29: 1087–1092.
|
[25] | Uchiba M, Okajima K, Oike Y (2004) Activated protein C induces endothelial cell proliferation by mitogen-activated protein kinase activation in vitro and angiogenesis in vivo. Circ Res 95: 34–41.
|
[26] | Joyce DE, Grinnell BW (2002) Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-kappaB. Crit Care Med 30: S288–293.
|
[27] | Cheng T, Liu D, Griffin JH (2003) Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat Med 9: 338–342.
|
[28] | Matsui T, Tao J, del Monte F (2001) Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 104: 330–335.
|
[29] | Gao F, Gao E, Yue TL (2002) Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 105: 1497–1502.
|
[30] | Gaudreault N, Perrin RM, Guo M, Clanton CP, Wu MH, et al. (2008) Counter regulatory effets of PKCβII and PKCδ on coronary endothelial permeability. Arterioscler Thromb Vas Biol 28: 1527–1533.
|
[31] | Rubanyi GM (1993) The role of endothelium in cardiovasucular homeostasis and diseases. J Cardiovasc Pharmacol 22: S1–14.
|
[32] | Swaidi JA, Hamasaki S, Higano ST (2000) Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial Dysfunction. Circulation 101: 948–954.
|
[33] | Dossumbekova A, Berdyshev EV, Gorshkova I (2008) Akt activates NOS3 and separately restores barrier integrity in H2O2-stressed human cardiac microvascular endothelium. Am J Physiol Heart Circ Physiol 295: 2417–2426.
|